1. Young NS. Acquired aplastic anemia. Ann Intern Med. 2002; 136:534–46.
Article
2. Hahn JS. Immunopathogenesis of aplastic anemia. Korean J Hematol. 1985; 20:87–94.
3. Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis. 1978; 137:298–308.
Article
4. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med. 1994; 330:949–55.
5. Muranyi W, Bahr U, Zeier M, van der Woude FJ. Hantavirus infection. J Am Soc Nephrol. 2005; 16:3669–79.
Article
6. Khan AS, Ksiazek TG, Peters CJ. Hantavirus pulmonary syndrome. Lancet. 1996; 347:739–41.
Article
7. Kim MS, Lee SH, Park JW, Do J, Yoon KW. A case of hantavirus pulmonary syndrome with hemorrhagic fever with renal syndrome. Korean J Med. 2007; 73:651–5.
8. Kim YS, Jee YK, Bai SJ, Yun SC, Kim KY. A case of hantavirus pulmonary syndrome. Tuberc Respi Dis. 1997; 44:1382–9.
9. Osaki M, Matsubara K, Iwasaki T, et al. Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease. Ann Hematol. 1999; 78:83–6.
Article
10. Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol. 1995; 146:552–79.
11. Peters CJ, Simpson GL, Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med. 1999; 50:531–45.